0 Commentaires
0 Parts
100 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Connectez-vous pour aimer, partager et commenter!
-
Regional Analysis of the Tremfya MarketThe rising burden of chronic inflammatory and autoimmune disorders has significantly increased demand for targeted biologic therapies. Among these, Tremfya (guselkumab) has emerged as a leading treatment option for moderate-to-severe plaque psoriasis and psoriatic arthritis. Strong Tremfya drug market growth, expanding guselkumab market applications, and increasing demand within...0 Commentaires 0 Parts 328 Vue 0 Aperçu
-
Tremfya Market: Key Developments Transforming Patient CareAccording to a new report by Polaris Market Research, the global Tremfya market was valued at USD 4.2 billion in 2025 and is projected to reach USD 7.99 billion by 2034, expanding at a CAGR of 7.40% over the forecast period. Growth is underpinned by rising adoption of biologic therapies, expanding regulatory approvals across inflammatory indications, and accelerating investment in...0 Commentaires 0 Parts 126 Vue 0 Aperçu
-
U.S. Tremfya Market Forecast to Witness Steady Growth During 2025–2034The U.S. Tremfya Market is witnessing significant transformation, shaped by innovation, evolving consumer expectations, regulatory shifts, and global economic trends. Polaris Market Research’s latest report, U.S. Tremfya Market, offers a holistic view of the market. It examines the market’s structure, growth drivers, competitive landscape, and future potential to provide a...0 Commentaires 0 Parts 134 Vue 0 Aperçu